Edition:
United Kingdom

Neuland Laboratories Ltd (NEUL.NS)

NEUL.NS on National Stock Exchange of India

869.40INR
10:24am GMT
Change (% chg)

Rs11.05 (+1.29%)
Prev Close
Rs858.35
Open
Rs859.90
Day's High
Rs875.85
Day's Low
Rs849.95
Volume
22,282
Avg. Vol
32,396
52-wk High
Rs1,727.00
52-wk Low
Rs849.95

Chart for

About

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides Custom Manufacturing Solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates. Its geographical segments include Europe, India, USA and Rest of the world. The Company's API... (more)

Overall

Beta: 0.94
Market Cap(Mil.): Rs9,459.51
Shares Outstanding(Mil.): 8.88
Dividend: 2.00
Yield (%): 0.19

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Neuland Labs ‍approves purchase of Arch Pharmalabs' manufacturing facility

* Says ‍approved purchase of manufacturing facility owned by Arch Pharmalabs Limited​ Source text - http://bit.ly/2AkzH24 Further company coverage:

22 Nov 2017

BRIEF-India's Neuland Labs Sept-qtr profit falls

* Sept quarter profit 25.9 million rupees versus 102.3 million rupees year ago

22 Nov 2017

BRIEF-Neuland Laboratories appoints Amit Agarwal as CFO

* Says ‍appointment of Amit Agarwal as chief financial officer​ Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-India's Neuland Labs June-qtr profit falls

* June quarter profit 23 million rupees versus 95.1 million rupees year ago

11 Sep 2017

BRIEF-Neuland Laboratories appoints D. Saharsh Rao as CFO

* Says appointed D. Saharsh Rao, as chief financial officer of company Source text: (http://bit.ly/2w57BFI) Further company coverage:

17 Aug 2017

Earnings vs. Estimates